Key result
Severely reduced kidney function (eGFR <15 ml/min/1.73m2) in patients hospitalized with acute decompensated heart failure was independently associated with increased 1-year mortality (OR 2.30).
Why the study?
Does reduced kidney function predict 1-year mortality in patients hospitalized with acute decompensated heart failure?
Observational (n=5,391)
Yes
Does reduced kidney function predict 1-year mortality in patients hospitalized with acute decompensated heart failure?
Odds Ratio: 2.3 (95% CI 1.76–3)
Severely reduced eGFR is highly prevalent in ADHF and strongly predicts 1-year mortality, though BUN may be a superior prognostic marker.
Severely reduced eGFR flags high 1-year mortality risk in community ADHF; extends single-center data but leaves BUN superiority open for validation.
BACKGROUND: Kidney dysfunction is prevalent and impacts prognosis in patients with acute decompensated heart failure (ADHF). However, most previous reports were from a single hospital, limiting their generalizability. Also, contemporary data using new equation for estimated glomerular filtration rate (eGFR) are needed. METHODS AND RESULTS: We analyzed data from the ARIC Community Surveillance for ADHF conducted for residents aged ≥55 years in four US communities between 2005-2011. All ADHF cases (n = 5, 391) were adjudicated and weighted to represent those communities (24,932 weighted cases). The association of kidney function (creatinine-based eGFR by the CKD-EPI equation and blood urea nitrogen [BUN]) during hospitalization with 1-year mortality was assessed using logistic regression. Based on worst and last serum creatinine, there were 82.5% and 70.6% with reduced eGFR (<60 ml/min/1.73m2) and 37.4% and 26.6% with severely reduced eGFR (<30 ml/min/1.73m2), respectively. Lower eGFR (regardless of last or worst eGFR), particularly eGFR <30 ml/min/1.73m2, was significantly associated with higher 1-year mortality independently of potential confounders (odds ratio 1.60 [95% CI 1.26-2.04] for last eGFR 15-29 ml/min/1.73m2 and 2.30 [1.76-3.00] for <15 compared to eGFR ≥60). The association was largely consistent across demographic subgroups. Of interest, when both eGFR and BUN were modeled together, only BUN remained significant. CONCLUSIONS: Severely reduced eGFR (<30 ml/min/1.73m2) was observed in ~30% of ADHF cases and was an independent predictor of 1-year mortality in community. For prediction, BUN appeared to be superior to eGFR. These findings suggest the need of close attention to kidney dysfunction among ADHF patients.
No takes yet. Share an insight, caveat, or question.
Matsushita et al. (2017) conducted an observational in Acute decompensated heart failure (ADHF) (n=5,391). Severely reduced eGFR (<15 ml/min/1.73m2) vs. eGFR ≥60 ml/min/1.73m2 was evaluated on 1-year mortality (OR 2.30, 95% CI 1.76-3.00). Severely reduced kidney function (eGFR <15 ml/min/1.73m2) in patients hospitalized with acute decompensated heart failure was independently associated with increased 1-year mortality (OR 2.30).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: